Biomarkers and genomics at ASCO 2027
Jun 4–8, 2027 Chicago, IL ~44k attendees Website
44 organizations at ASCO 2027 present work in biomarkers and genomics: 43 diagnostics, technology and service companies and 1 advocacy group, society, cancer center, publisher or agency. 44 of them have their own page in this guide. As of Oct 8, 2026.
Showing 1–20 of 44 organizations
| Organization | ASCO 2027 Attendance |
|---|---|
1Cell.Ai Cupertino, CA | |
Single-cell multi-omics testing of live circulating tumor cells from blood, with AI models that predict homologous recombination deficiency. | Booth Exhibiting at Booth 24016 |
Adaptive Biotechnologies Seattle, WA | |
Immune-sequencing company whose clonoSEQ test measures minimal residual disease in myeloma, leukemia and lymphoma. | Booth Exhibiting at Booth 17151 |
Agendia Irvine, CA | |
Breast cancer genomics company whose MammaPrint and BluePrint tests gauge recurrence risk and tumor subtype to guide early-stage treatment. | Booth Exhibiting at Booth 27147 |
Agilent Technologies Santa Clara, CA | |
Laboratory technology company whose clinical offerings include pathology staining systems, PD-L1 companion diagnostics and genomic assays for cancer testing. | Booth Exhibiting at Booth 13149 |
Aignostics Berlin, Germany | |
AI pathology company analyzing tissue images and multimodal data for biopharma, from target discovery to trials and companion diagnostics. | Booth Exhibiting at Booth IH15 |
Almac Craigavon, UK | |
Diagnostic services unit of the Almac group, running biomarker and companion diagnostic development, multi-omic analysis and clinical testing for drug trials. | Booth Exhibiting at Booth 15157 |
Amoy Diagnostics Xiamen, China | |
Chinese maker of PCR and sequencing kits that detect tumor gene mutations, including companion diagnostics widely used in lung cancer. | Booth Exhibiting at Booth 22114 |
Arima Genomics Orlando, FL | |
Genomics company whose CLIA lab tests tumors using whole-genome sequencing plus 3D genome structure; also sells research kits and software. | Booth Exhibiting at Booth 10082 |
BillionToOne Northstar Menlo Park, CA | |
Oncology testing arm of BillionToOne, using single-molecule counting NGS for liquid biopsy therapy selection and treatment response monitoring. | Booth Exhibiting at Booth 10071 |
Biocartis Mechelen, Belgium | |
Maker of the Idylla automated PCR system for rapid molecular testing of tumor samples to guide treatment. | Booth Exhibiting at Booth 37075 |
Biodesix Louisville, CO | |
Diagnostics company with blood-based lung cancer tests, plus development services for biopharma diagnostic and drug programs. | Booth Exhibiting at Booth 30099 |
BostonGene Waltham, MA | |
AI and multi-omic tumor profiling company combining genomic, transcriptomic and immune data to guide treatment and biopharma trials. | Booth Exhibiting at Booth 33147 |
Burning Rock Dx Guangzhou, China | |
Chinese NGS cancer testing company offering tissue and liquid biopsy assays, companion diagnostic development and a multi-cancer early detection test. | Booth Exhibiting at Booth 14157 |
Caris Life Sciences Irving, TX | |
Tumor profiling lab analyzing DNA, RNA and proteins, paired with AI models and a large molecular and clinical database. | Booth Exhibiting at Booth 31093 |
Creatv Bio Rockville, MD | |
Developer of blood tests for solid tumors that aim to screen, give prognosis, predict treatment response and detect recurrence or residual disease. | Booth Exhibiting at Booth 27069 |
Delphi Diagnostics Houston, TX | |
Texas company commercializing the Endocrine Activity Index, a test of endocrine activity in stage II–III HR-positive, HER2-negative breast cancer. | Booth Exhibiting at Booth 29069 |
Elephas Madison, WI | |
Developer of a live-tumor-tissue test that measures how a biopsy responds to immunotherapy to predict benefit before treatment starts. | Booth Exhibiting at Booth 37121 |
Exact Sciences Madison, WI | |
Cancer screening and diagnostics company, now part of Abbott, known for the Cologuard colon cancer screening test and Oncotype DX breast cancer test. | Booth Exhibiting at Booth 22094 |
Exai Bio Palo Alto, CA | |
Liquid biopsy company using RNA signals and AI to detect cancer early and profile tumor biology from a blood sample. | Booth Exhibiting at Booth IH19 |
Foundation Medicine Cambridge, MA | |
Genomic profiling company whose tissue and blood tests identify tumor alterations to guide treatment and support drug research. | Booth Exhibiting at Booth 19131 |
Instantly find 20 buyers in biomarkers and genomics
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse ASCO 2027 by
Organization type
Focus
- Clinical trials 58
- Biomarkers and genomics 44
- AI and data 38
- Blood cancers 36
- Lung cancer 28
- Genitourinary cancers 24
- Gastrointestinal cancers 21
- Breast cancer 18
- Immunotherapy 17
- Imaging and radiation 17
- Patient support and survivorship 14
- Antibody-drug conjugates 9
- Cell and gene therapy 8
- Melanoma and skin cancers 7
- Gynecologic cancers 6
Exhibit hall
Everyone
Not affiliated with the American Society of Clinical Oncology. Organization details are derived from ASCO’s published exhibitor list and each exhibitor’s own profile and website. Submit a correction